ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,727, issued on June 9, was assigned to Abbisko Therapeutics Co. Ltd.
"EFGR inhibitor, preparation method therefor and application thereof" was invented by Fei Yang (Shanghai), Shuqun Yang (Shanghai), Hongping Yu (Shanghai), Zhui Chen (Shanghai) and Yaochang Xu (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "An EGFR inhibitor having the structure of formula (I), a preparation method therefor, a pharmaceutical composition containing same, a use of same as an EGFR inhibitor, and a use of same in preparing a drug for treating and/or preventing a cancer, a tumor, or a metastatic disease at least partially related to an EGFR exon 20 insertion, del...